<DOC>
	<DOCNO>NCT00579917</DOCNO>
	<brief_summary>The purpose study understand help survivor bone marrow transplant stem cell transplant ( BMT/SCT ) emotional distress . BMT/SCT become common type treatment cancer hematological disorder ( blood disease ) . For reason , concern adjustment treatment may difficult many person . We find 25 % BMT/SCT survivor still feel anxious distressed illness treatment least one year follow transplant . This study one first study impact counsel BMT/SCT survivor . The study carry Memorial Sloan-Kettering Cancer Center , Mount Sinai Medical Center , Hackensack University Medical Center .</brief_summary>
	<brief_title>Behavioral Intervention For BMT/SCT Survivors</brief_title>
	<detailed_description>The use bone marrow stem cell transplantation ( BMT/SCT ) treatment cancer increase five-fold last decade . Among cancer treat BMT/SCT Hodgkin 's Lymphoma , non-Hodgkin 's Lymphoma , multiple myeloma , leukemias acute lymphoblastic ( ALL ) , acute myelogenous ( AML ) , chronic lymphocytic ( CLL ) , chronic myelogenous ( CML ) . With development non-myeloablative transplant ( either `` mini '' reduce intensity transplant ) patient unable tolerate standard BMT/SCT , use procedure expect increase substantially next five year . BMT/SCT adversely affect almost every aspect patient 's life ( 1 ; 2 ) . A standard ( fully ablative ) transplant involve condition dose intensive chemotherapy , without total body irradiation . Although various medical regimen supportive psychosocial service use reduce intensity side effect , symptom may persist . Moreover , drug use control side effect often aversive side effect . Thus , patient must tolerate protracted course treatment highly aversive invasive time life disrupt fearful survival . A common complaint among survivor problem go unaddressed , types adjustment problem appear become intense first year post treatment , physical functioning stabilize contact BMT/SCT clinical care team wane ( 5 ; 10 ) .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Have significant psychological distress measure either : PTSD ONLY score 1.0 standard deviation mean PTSD ChecklistCivilian ( PCLC ) , score meet PCLC symptom cluster criterion 3 symptom cluster ( i.e . reexperiencing , numb avoidance combine , hyperarousal ) 4 symptom cluster ( i.e. , reexperiencing , numb , avoidance , hyperarousal ) ; DISTRESS WITH SOME PTSD score meet clinically significant impairment Brief Symptom Inventory ( BSI ) global distress index score meet PCLC symptom cluster criterion least one PCLC symptom cluster 3 symptom cluster ( i.e . reexperiencing , numb avoidance combine , hyperarousal ) 4 symptom cluster ( i.e. , reexperiencing , numb , avoidance , hyperarousal ) Do substance abuse disorder Do cognitive impairment indicate score 3 low MiniMental Status Exam Absence psychotic symptomatology Do active suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Survivor</keyword>
	<keyword>Behavioral Intervention</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>Stem Cell Transplantation</keyword>
</DOC>